Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Gastric Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    January 2022
  1. PARK JH, Yeo JH, Kim YS, Park I, et al
    Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis.
    Am J Clin Oncol. 2022 Jan 6. pii: 00000421-900000000-98512.
    PubMed     Abstract available


    July 2021
  2. ABALI H, Yalcin S, Onal HC, Dane F, et al
    A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group
    Am J Clin Oncol. 2021;44:301-307.
    PubMed     Abstract available


    June 2021
  3. MISRA S, Yeshala SK, Singh S, Singh RK, et al
    A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers.
    Am J Clin Oncol. 2021 Jun 29. pii: 00000421-900000000-98549.
    PubMed     Abstract available


    May 2021
  4. OGATA T, Narita Y, Kumanishi R, Nakazawa T, et al
    Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer: A Retrospective Cohort Study.
    Am J Clin Oncol. 2021 May 24. pii: 00000421-900000000-98560.
    PubMed     Abstract available


    April 2021
  5. ABDEL-RAHMAN O, Mulder K, Easaw J
    Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer: A Real-world Study.
    Am J Clin Oncol. 2021;44:158-161.
    PubMed     Abstract available


    March 2021
  6. PARK JH, Yeo JH, Kim YS, Park I, et al
    Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.
    Am J Clin Oncol. 2021 Mar 12. pii: 00000421-900000000-98590.
    PubMed     Abstract available


    November 2020
  7. DE LEO AN, Bates JE, Lockney NA, Mendenhall NP, et al
    Radiotherapy in Early-stage Gastric MALT: Improved Survival Without Increased Cardiac Death.
    Am J Clin Oncol. 2020;43:770-775.
    PubMed     Abstract available


    October 2020
  8. DIAZ DEL ARCO C, Estrada Munoz L, Sanchez Pernaute A, Ortega Medina L, et al
    Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Am J Clin Oncol. 2020 Oct 20. doi: 10.1097/COC.0000000000000770.
    PubMed     Abstract available


    October 2019
  9. SEO HS, Jung YJ, Kim JH, Lee HH, et al
    The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.
    Am J Clin Oncol. 2019 Oct 29. doi: 10.1097/COC.0000000000000627.
    PubMed     Abstract available


    July 2019
  10. ZE-LONG Y, Guo-Hui M, Lin Z, Wei-Hong Y, et al
    Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States.
    Am J Clin Oncol. 2019;42:581-587.
    PubMed     Abstract available


    February 2019
  11. JIN Z, Holubek M, Sukov WR, Sattler CA, et al
    Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.
    Am J Clin Oncol. 2019;42:190-195.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: